Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

RNA Medicines: Advancements Leading To Investments

Dec 01 2022

• By Amanda Micklus

Watering — • Source: Shutterstock

Related Content

Alnylam’s Amvuttra To Take Off From Onpattro’s Runway

Jun 14 2022

RNAi Partners Vie To Lead Race To Cure Hepatitis B

Sep 04 2020

CSL Licenses Arcturus mRNA Technology, But COVID-19 Vaccine Remains Uncertain

Nov 02 2022

Related Companies

Alnylam Pharmaceuticals Inc.

Moderna, Inc.

Ionis Pharmaceuticals, Inc.

BioNTech SE

Suzhou Abogen Biosciences

Eli Lilly and Company

CureVac NV

Evox Therapeutics Limited

MiNA Therapeutics Limited

ProQR Therapeutics N.V.

Dicerna Pharmaceuticals, Inc.

Novo Nordisk A/S

Avidity Biosciences, Inc.

DTx Pharma

Janssen Pharmaceuticals Inc.

Arrowhead Pharmaceuticals, Inc.

Merck & Co., Inc.

Orna Therapeutics, Inc.

Beam Therapeutics Inc.

Pfizer Inc.

Additional Topics

Growth Gene Therapy Deals Financing Innovation Outlook 2023 BioPharmaceutical

More from Outlook Archive

More from Outlook 2024

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.